Genpharmasec Ltd Share Price

Q: What is the share price of Genpharmasec Ltd today?

Genpharmasec Ltd share price as on 18 Nov 2025 is ₹1.53

Trading

BSE: 531592 Small Cap ISIN: INE861N01036

As on 19 November 2025 at 01:26 IST

₹1.53

-0.04

(-2.55%)

Sell Buy

Over 1 Month

-11.30%

Over 6 Months

-30.84%

Over 1 Year

-44.72%

Over 3 Years

-45.49%

Genpharmasec Ltd Summary

Close ₹1.57

Open ₹1.58

High ₹1.59

Low ₹1.56

Volume 3,28,409

Net Turnover (in Cr) ₹0.051

52Wk High ₹4.32

52Wk Low ₹1.42

52Wk High / Low

1.42

4.32

Genpharmasec Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹86.93

EPS (TTM) 0.06

Book Value (BV) 1.24

Div. Yield -

P/E (TTM) 26.17

Price/Book Value 1.26

Delivery % 73.76 %

Face Value 1

Key Ratios

PE Ratio 47.25

PB Ratio 1.58

EV to Sales 3.12

PEG Ratio -

ROA 3.53

ROE 3.59

Debt-Equity 0.05

Net Profit Margin 7.49

Operating Profit Margin 11.74

Genpharmasec Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023
Total Revenue	36.78	31.06	25.62
Total Expenses	34.90	30.81	25.33
Profit Before Tax	1.88	0.25	0.28
Profit After Tax	1.23	-0.17	1.12
Operating Profit After Depreciation	2.31	0.66	0.34

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023
Fixed Assets	7.58	0.84	0.10
Total Non Current Assets	52.58	30.15	0.95
Total Current Assets	27.32	40.97	18.93
Total Assets	79.89	71.13	19.88
Total Shareholder's Fund	65.16	64.40	15.33

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023
Net Cash From Operating Activities	2.99	-2.95	-3.06
Net Cash Used In Investing Activities	-15.30	-28.06	0.36
Net Cash Used In Financing Activities	-1.25	47.85	3.08

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	36.39	31.12	25.62	27.41	21.64
Total Expenses	32.95	30.66	25.33	27.86	20.13
Profit Before Tax	3.45	0.47	0.28	-0.44	1.51
Profit After Tax	2.47	0.05	1.12	-0.21	1.26
Operating Profit After Depreciation	3.72	0.86	0.34	-0.44	1.51

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	0.36	0.10	0.10	0.10	0.05
Total Non Current Assets	51.26	30.44	0.95	0.11	1.04
Total Current Assets	27.83	40.04	18.93	21.54	26.78
Total Assets	79.09	70.47	19.88	21.65	27.82
Total Shareholder's Fund	66.55	64.57	15.33	15.37	20.66

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	3.45	-2.27	-3.06	-2.34	-2.13
Net Cash Used In Investing Activities	-16.45	-29.03	0.36	0.42	-1.41
Net Cash Used In Financing Activities	-0.44	47.89	3.08	-	4.50

Particulars (in ₹ Cr.)	2025-09	2025-06	2025-03	2024-12	2024-09
Total Revenue	32.64	12.04	14.01	8.48	6.03
Total Expenses	33.11	11.10	15.01	7.75	5.91
Profit Before Tax	-0.80	1.24	-0.43	1.28	0.50
Profit After Tax	-1.18	1.22	-0.27	0.78	0.70
Operating Profit after Depreciation	-0.01	1.63	-0.06	1.54	0.87

Particulars (in ₹ Cr.)	2025-09	2025-06	2025-03	2024-12	2024-09
Total Revenue	31.56	12.11	13.56	8.34	5.77
Total Expenses	31.06	11.11	14.55	7.37	5.52
Profit Before Tax	1.38	1.70	-0.03	1.74	1.03
Profit After Tax	0.82	1.56	-0.23	1.13	1
Operating Profit after Depreciation	1.50	1.82	0.07	1.90	1.11

Genpharmasec Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 1.56

S2 1.54

S3 1.53

Pivot 1.57

R1 1.59

R2 1.60

R3 1.62

Moving Average

20 SMA 1.64

50 SMA 1.79

100 SMA 1.90

200 SMA 2.02

Genpharmasec Ltd Corporate Actions

No available data

AGM Date: 22 Dec 2020

Outcome of Board Meeting. Pursuant Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that 28th Annual General Meeting of the members of the Company was held on Tuesday, 22nd December, 2020, at 11.00 A.M. at Kriish Cottage, C-101/201, Manas Building, Nr St. lawrence High School, Devidas Lane, Borivali (w), Mumbai - 400103. (As Per BSE Announcement dated on 22.12.2020) Generic Pharmasec Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. INTIMATION OF THE VOTING RESULTS OF THE 28TH ANNUAL GENERAL MEETING OF GENERIC PHARMASEC LIMITED (FORMERLY KNOWN AS ADI RASAYAN LIMITED) ('THE COMPANY') AS PER REGULATION 44 (3) OF THE SEBI (LISTING OBLIGATION & DISCLOSURE REQUIREMENT), 2015. (As per BSE Announcement Dated on 23/12/2020)

AGM Date: 30 Sep 2021

AGM 30/09/2021 Intimation For Cut-Off Date And Notice Of Closure Of Register Of Members And Share Transfer Books For The Purpose Of AGM For FY 2020-2021. Proceedings of the 29th Annual General Meeting of the Company held on Thursday 30th September 2021 at 09.30 AM at Kriish Cottage C-101/201 Manas Building Nr St. lawrence High School Devidas Lane Borivali (w) Mumbai 400103. (As Per BSE Announcement Dated on 9/30/2021 5:17:55 AM) Generic Pharmasec Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE announcement Dated on 01.10.2021) REVISED VOTING RESULTS OF THE 29TH ANNUAL GENERAL MEETING OF GENERIC PHARMASEC LIMITED (THE COMPANY) AS PER REGULATION 44 (3) OF THE SEBI (LISTING OBLIGATION & DISCLOSURE REQUIREMENT) 2015.(As Per BSE Announcement Dated on 10/7/2021 5:21:36 AM)

AGM Date: 29 Sep 2022

AGM 29/09/2022 Outcome of Board Meeting held on 05th September 2022 (As Per BSE Announcement dated on 05.09.2022) Proceedings of the 30th Annual General Meeting of the Members of Genpharmasec Limited. Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that 30th Annual General Meeting of the Members of the Company was held on Thursday 29th September, 2022 at 9.30 A.M. at Kriish Cottage C-101/201 Manas Building Near St. Lawrence High School Devidas Lane Borivali (West) Mumbai - 400 103 to transact the businesses set out in the Notice of the 30th Annual General Meeting (As Per BSE Announcement Dated on 29/09/2022)

AGM Date: 23 Sep 2023

1. Considered and approved the Board Report for the year ended 31st March, 2023. 2. Considered and approved the notice of 31st Annual General meeting of the Members of the Company, which will be held on Saturday 23d September, 2023 at 09.30 A.M. at Kriish Cottage, C-101/201, Manas Building, Near St. Lawrence High School, Devidas Lane, Borivali (West), Mumbai 400103. 3.The Share Transfer Book and the Member''s Registers of the Company shall remain closed from 17th September, 2023 to 23rd September, 2023 (both days inclusive)in connection with the Annual General Meeting of the Company. 4. Further Company has fixed 16th September, 2023 as the CUT-OFF DATE 5. Considered and approved the appointment of M/S Jaymin Modi & Co as the Scrutinizer of the Annual General Meeting of the company to be held on Saturday 23rd September, 2023. Pursuant to Reg. 30 of SEBI(LODR) Reg. 2015, we hereby inform that 31st Annual General Meeting (AGM) of the Members of the Meeting was being held today on 23rd September, 2023 at 09:30 AM at Kriish Cottage, Devidas Lane, Boriwali (W), to transact the business as set out in the notice of AGM. The meeting concluded at 10:01 AM. Pursuant to Reg. 30 of SEBI (LODR) Reg. 2015, this is to inform you that the 31st Annual General Meeting of the members of the Company was held today on 23rd September, 2023 at 09:30 AM at Kriish Cottage, Devidas Lane, Borivali (West), to transact the business mentioned under the notice of the AGM. The meeting was concluded at 10:01 AM. (As Per BSE Announcement Dated on 23/09/2023) Pursuant to Reg. 44(3) of SEBI(LODR) Reg. 2015, we are enclosing herewith, the voting results and scruntinizer''s report of the 31st AGM held on 23rd September, 2023 at 09:30 AM at Kriish Cottage, Devidas lane, Boriwali (W). The resolutions set forth in the notice have been passed with requisite majority. Mr. Jaymin modi, appointed as a scruntinizer for conducting AGM has submitted his report on 25th September, 2023 and the said report is been declared by the CS of the Company , duly authorise by the chairman i.e. on 26th September,2023. (As per BSE Announcement Dated on 26/09/2023)

AGM Date: 23 Jul 2024

Intimation of Book closure for the Annual General Meeting to be held on 23rd July, 2024. Outcome of the Meeting of Board of Directors held on Thursday, 27th June, 2024 at 02:30 P.M. Disclosure of Voting Result and Scrutinizers Report of the 32nd Annual General Meeting of the Company held on 23rd July 2024 at 11.00 A.M. (As Per BSE Announcement dated on 23.07.2024)

AGM Date: 29 Sep 2025

Notice of 33rd Annual General Meeting of the company to be held on September 29, 2025. Submission of proceeding of the 33rd Annual General Meeting of the Members of the Genpharmasec Limited held on Monday, 29th September, 2025. (As Per Bse Announcement dated on 29/09/2025)

EGM Date: 02 Jun 2023

Pursuant to Regulations 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Schedule III of the said Regulations, we inform you that the Board of Directors of the Company at its meeting held today, i.e., Monday May 8, 2023, inter alia, has approved the following items: 1. Considered and approved the Increase in the Authorized Share Capital of the Company from Rs. 30,00,00,000 /- (Thirty Crore) to Rs. 56,00,00,000/- (Fifty-Six Crore), and consequent alteration of Clause V of the Memorandum of Association of the company, subject to the approval of members; The Board has fixed i.e. 26th May, 2023 as the 'Cut Off Date' for determining the eligibility of the Member to Vote by Electronic means. Further, pursuant to Regulation 42 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, the Register of Members and Share Transfer Book of the company will remain close from Friday 26th May, 2023 to Friday 02nd June, 2023 (both days inclusive) for the purpose of Extra-Ordinary General Meeting of the Company to be held on Friday 02nd June, 2023 at 11.30 A.M. through Video Conferencing / other Audio-Visual Means. Section 108 of the Companies Act, 2013, Rule 20 of the Companies (Management and Administration) Rules, 2014 and Regulation 44 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, the Company is providing e-voting facility to the shareholders of the Company which shall start from Monday 29th May, 2023 at 09:00 A.M. (IST) and ends on Thursday, 1st June, 2023 at 05:00 P.M. (IST). (As Per BSE Announcement Dated on 09.05.2023) EGM 02/06/2023 (As Per BSE Bulletin Dated on 09.05.2023) Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the Notice of EOGM and E-Voting together with Explanatory Statement sent to the members of the Company whose names appeared on the Register of Members/ List of Beneficial Owners as on Friday, 05th May, 2023 i.e. Cut-off date. (As Per BSE Announcement Dated on 10.05.2023) In terms of the Regulation 30 read with Schedule III of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we would like to inform you that Extra-Ordinary General Meeting ('EOGM') of the Company was held on Friday 02nd June, 2023 at 11.30 am & the requisite quorum being present, the meeting commenced at 11:32 a.m., in compliance with the provisions of the Companies Act, 2013 ('Act') and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'). Please find enclosed the Summary of the Proceedings of the 1st Extra-Ordinary General Meeting for the Financial Year 23-24. The meeting was concluded at 12.13 p.m. (As per BSE Announcement Dated on 02/06/2023) This is in continuation to our letter dated May 8, 2023 regarding submission of EGM Notice seeking approval of Shareholders of the company by way of Ordinary Resolution for: Increase in Authorised Share Capital of the Company; and By way of Special Resolution for: Alteration of Memorandum of Association, Increase in borrowing limits, Power to create charge on the assets of the Company to secure borrowings up to 500 crores pursuant to section 180(1)(a) of the companies act, 2013, Increase in the limits applicable for making investments/extending loans and giving guarantees or providing securities in connection with loans to persons/ bodies corporate. In this regard, Mr. Jaymin Modi, Practicing Company Secretary (Membership No. 44248) who was appointed as the Scrutinizer. (As Per BSE Announcement Dated on 05/06/2023) This is in continuous to our earlier intimation of proceedings of Extra-Ordinary General Meeting dated June 2, 2023 filed at 4.46 p.m. We have noticed some unintentional oversight served in number of members attending the EGM. So, this is to inform you that we are filling revised intimation of proceedings of EGM with the correct number of Members attending the same. Rest all details remains unchanged. (As per BSE Announcement Dated on 07/06/2023)

Genpharmasec Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Adani Enterprises Ltd	₹2,464.90	₹3,18,633.29
Premier Energies Ltd	₹1,015.45	₹45,999.31
Aegis Logistics Ltd	₹797.60	₹27,995.76
Redington Ltd	₹296.50	₹23,179.61
RRP Semiconductor Ltd	₹11,549.95	₹15,735.65

Genpharmasec Ltd Top Mutal Funds Invested

No data available

Genpharmasec Ltd News

Genpharmasec to announce Quarterly Result

On 6 November 2025

27 Oct 2025, 04:43 pm

Genpharmasec AGM scheduled

On 29 September 2025

09 Sep 2025, 04:58 pm

Genpharmasec to hold board meeting

On 2 September 2025

28 Aug 2025, 04:46 pm

Genpharmasec to declare Quarterly Results

On 7 August 2025

02 Aug 2025, 09:55 am

Genpharmasec to table results

On 21 May 2025

13 May 2025, 05:13 pm

Genpharmasec Ltd Stock Analysis

Annual revenue for Genpharmasec Ltd increased by 16.93% to ₹36.39 crore in FY 2025 from ₹31.12 crore in FY 2024.
Annual Net Profit for Genpharmasec Ltd increased by 5243.72% to ₹2.47 crore in FY 2025 from ₹0.05 crore in FY 2024.
Promoter Shareholding in Genpharmasec Ltd remains unchanged by 0.00% in the most recent quarter, from 29.98% in June 2025 to 29.98% in September 2025.
Genpharmasec Ltd delivered a 1-year return of -44.72% compared to the Nifty 50, which provided a return of 10.91% as of the last trading session.
Genpharmasec Ltd share price moved down by 2.55% from its previous close of INR ₹1.57. The latest Genpharmasec Ltd share price is INR ₹1.53.
Genpharmasec Ltd share price today has been at a low of 1.52 and a high of 1.59. Over the past 52 weeks, the Genpharmasec Ltd share price has seen a low of 1.42 and a high of 4.32.